A comprehensive view of New Drug / Biologic License Application (NDA / BLA). This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Pfizer Applies for Patent on Anti-Proliferative Agents for Treating Pah
Published: April 19, 2024 by Pharmaceutical Patent News
INTERNATIONAL PATENT: REGENERON PHARMACEUTICALS, INC. FILES APPLICATION FOR "METHODS OF TREATING CANCER WITH BISPECIFIC EGFR X CD28 ANTIBODIES ALONE OR IN COMBINATION WITH ANTI-PD-1 ANTIBODIES"
Published: April 17, 2024 by U.S. Fed News
Patent Application Titled 'Treatment Of Vasculopathy With Prostacyclin And Mesenchymal Stem Cells' Published Online (USPTO 20240100003)
Published: April 17, 2024 by Heart Disease Daily
GSK's 5-in-1 meningococcal ABCWY vaccine candidate accepted for review by the FDA; vaccine aims to provide broad protection against the five most common bacterial groups that cause invasive meningococcal disease
Published: April 16, 2024 by GSK Group (GlaxoSmithKline)
INTERNATIONAL PATENT: PFIZER INC., ASTELLAS PHARMA INC. FILES APPLICATION FOR "COMBINATION OF TALAZOPARIB AND ENZALUTAMIDE IN THE TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER"
Published: April 15, 2024 by U.S. Fed News

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count